Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.
Saved in:
| Title: | Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. |
|---|---|
| Authors: | Khetan, Riya1 (AUTHOR), Lokman, Noor A.2 (AUTHOR), Eldi, Preethi3 (AUTHOR), Price, Zoe K.2,4 (AUTHOR), Oehler, Martin K.2,4,5 (AUTHOR), Brooks, Doug A.1,3 (AUTHOR), Blencowe, Anton1,2,5 (AUTHOR), Garg, Sanjay1,3 (AUTHOR), Ricciardelli, Carmela2,4 (AUTHOR) carmela.ricciardelli@adelaide.edu.au, Albrecht, Hugo1,5 (AUTHOR) hugo.albrecht@unisa.edu.au |
| Source: | International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8529. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
